Last reviewed · How we verify
Multimodal Intravenous Analgesia — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Multimodal Intravenous Analgesia (Multimodal Intravenous Analgesia) — Udayana University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Multimodal Intravenous Analgesia TARGET | Multimodal Intravenous Analgesia | Udayana University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Multimodal Intravenous Analgesia CI watch — RSS
- Multimodal Intravenous Analgesia CI watch — Atom
- Multimodal Intravenous Analgesia CI watch — JSON
- Multimodal Intravenous Analgesia alone — RSS
Cite this brief
Drug Landscape (2026). Multimodal Intravenous Analgesia — Competitive Intelligence Brief. https://druglandscape.com/ci/multimodal-intravenous-analgesia. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab